Back to top

Press Releases

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Amkor Technology, InnerWorkings, Stoneridge, TTM Technologies and WellCare Health Plans

AMKR INWK SRI TTMI WCG

Trades from $3

For Immediate Release

Chicago, IL – September 28, 2016 - Stocks in this week’s article include: Amkor Technology (NASDAQ: (AMKR - Free Report) -Free Report ), InnerWorkings (NASDAQ: (INWK - Free Report) -Free Report ), Stoneridge (NYSE: (SRI - Free Report) -Free Report ), TTM Technologies (NASDAQ: (TTMI - Free Report) -Free Report ) and WellCare Health Plans (NYSE: (WCG - Free Report) -Free Report ). Kevin Matras screens for companies showing their 'first' profit, and explains why they are ones to watch.

Screen of the Week written by Kevin Matras of Zacks Investment Research:

Why the P/S Ratio Is My Favorite Valuation Metric

This week, I'm going to focus on the Price to Sales ratio for finding great stocks at great values.

The Price to Sales ratio is a great valuation metric. And given the recent run-up in stocks, value, to me, is becoming more and more important.

In fact, aside from the Zacks Rank, if I could only use one item to screen and pick stocks with, this item would be the one.


Definition

Let's first start with a definition.

The Price to Sales ratio is simply: Price divided by Sales

If the Price to Sales ratio is 1, that means you're paying $1 for every $1 of sales the company makes.

A price to sales ratio of 2 means you're paying $2 for every $1 of sales the company makes.

As you might have guessed, the lower the Price the Sales ratio, the better.

A price to Sales ratio of .5 means you're paying 50 cents for every $1 of sales the company makes.

And paying less than a dollar for a dollar's worth of something is a good bargain.

One of the reasons I like the Price to Sales ratio is because it looks at sales rather than earnings, like the P/E ratio does.

And sales are harder to manipulate on an income statement than earnings.

Secondly, I'd be hard pressed to find a screen where adding the Price to Sales ratio didn't improve it.


Price to Sales Study

For me, I prefer to look for stocks with a Price to Sales ratio under 1. Although, I'm willing to go up to 4, depending on the industry.

But in my testing, those with a Price to Sales ratio of 1 or less produced the best returns. Between 1 and 2 also outperformed pretty significantly. But once you got over 4, the odds were against you.

But the best way to use it, I've found, is to find stocks with a Price to Sales ratio below the median for its Industry.

And that's what we'll be focusing on in this week's screen.


Screen Parameters

Projected Growth Rate greater than or equal to Projected Growth Rate for the S&P
(Above market growth rates.)

Last Earnings Surprise greater than 0
(Positive EPS Surprise)

Last Sales Surprise greater than 0
(Positive Sales Surprise)

Zacks Rank less than or equal to 2
(Only stocks with a Zacks Rank of a Strong Buy or Buy get through.)

Price to Sales less than or equal to Median Price to Sales for its Industry
(Valuations that are lower than their Industry.)

Price greater than or equal to $5

Avg. 20 Day Volume greater than or equal to 100,000


Stock Selections

Here are 5 stocks from this week's list:

Amkor Technology (NASDAQ: (AMKR - Free Report) -Free Report )
InnerWorkings (NASDAQ: (INWK - Free Report) -Free Report )

Stoneridge (NYSE: (SRI - Free Report) -Free Report )
TTM Technologies (NASDAQ: (TTMI - Free Report) -Free Report )
WellCare Health Plans (NYSE: (WCG - Free Report) -Free Report )

Sign up now for your 2 week free trial to the Research Wizard and get the rest of the stocks on this list. Start using this screen and the Price to Sales ratio in your own trading. Or create your own strategies and test them first before you invest. Know what to buy and when to sell.

Learn how today with the Research Wizard.

Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.


About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Get the full Report on AMKR - FREE

Get the full Report on INWK - FREE

Get the full Report on SRI - FREE

Get the full Report on TTMI - FREE

Get the full Report on WCG - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.


Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.